NCT07834437 A Comparison of Group Cognitive Behavioural Therapy (CBT) and Structured Activity Group for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
| NCT ID | NCT07834437 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Region Stockholm |
| Condition | ADHD |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-09-01 |
| Primary Completion | 2028-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-09-01 with a primary completion date of 2028-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Many adults with attention deficit hyperactivity disorder (ADHD) experience difficulties with inattention, planning, impulsivity and emotion regulation that impacts work and social life negatively also after treatment with medication. There are various psychological treatments aiming to improve these symptoms, but it is not known if they work or not. The goal of this clinical trial is to evaluate group cognitive behavioural therapy (CBT) for adults with attention deficit hyperactivity disorder (ADHD) in comparison to an active control group consisting of a discussion and activity group. Previous research suggests that group CBT works about equally well as other structured group activities. The main questions the researchers aim to answer are if group CBT work better than activity groups to: * Improve symptoms of ADHD * Improve general mental health and life quality * Improve every-day functioning The researchers also want to learn if group CBT or activity groups work better for some people with ADHD depending on individual characteristics such as * Type of symptoms, age, gender or co-occurring psychiatric diagnoses The comparison is a manualised structured activity group given at the same number of sessions and same group size. All participants will visit our clinics at 14 occasions. They will: * Fill in questionnaires before and after the group intervention, and online after 6, 12 and 24 months * Do an interview with an independent trained clinician about their daily functioning and difficulties related to ADHD symptoms before and after the group intervention, and after 6, 12 and 24 months
Eligibility Criteria
Inclusion Criteria: * Fulfilling criteria for ADHD * Motivation and practical possibility to participate in the treatment. Exclusion Criteria: * Ongoing psychosis * Ongoing suicidality/severe self-injury * Intellectual disability * Insufficient Swedish language skills.
Contact & Investigator
Jacqueline Borg, PhD
PRINCIPAL INVESTIGATOR
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services
Frequently Asked Questions
Who can join the NCT07834437 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying ADHD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07834437 currently recruiting?
Yes, NCT07834437 is actively recruiting participants. Contact the research team at jacqueline.borg@ki.se for enrollment information.
Where is the NCT07834437 trial being conducted?
This trial is being conducted at Stockholm, Sweden, Stockholm, Sweden.
Who is sponsoring the NCT07834437 clinical trial?
NCT07834437 is sponsored by Region Stockholm. The principal investigator is Jacqueline Borg, PhD at Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services. The trial plans to enroll 120 participants.